HRs for 1 year follow-up | |||
---|---|---|---|
Adjusted HR* (95% CI) MEN | Adjusted HR* (95% CI) WOMEN | Adjusted HR*,† (95% CI) TOTAL | |
Preventive drugs dispensed within 28 days postdischarge | |||
None | Ref | Ref | Ref |
BB only | 0.81 (0.59 to 1.11) | 0.81 (0.51 to 1.27) | 0.82 (0.63 to 1.06) |
ST only | 0.71 (0.47 to 1.07) | 0.83 (0.50 to 1.38) | 0.76 (0.56 to 1.04) |
ACEi/ARB only | 0.90 (0.70 to 1.16) | 1.11 (0.81 to 1.53) | 0.98 (0.81 to 1.20) |
BB+ST | 0.36 (0.22 to 0.58) | 0.61 (0.36 to 1.02) | 0.46 (0.32 to 0.64) |
BB+ACEi/ARB | 0.58 (0.42 to 0.80) | 0.88 (0.89 to 1.31) | 0.68 (0.53 to 0.88) |
ST+ACEi/ARB | 0.70 (0.52 to 0.95) | 0.75 (0.50 to 1.13) | 0.73 (0.57 to 0.93) |
BB+ST+ACEi/ARB | 0.47 (0.35 to 0.62) | 0.54 (0.37 to 0.79) | 0.50 (0.40 to 0.63) |
*Cox multivariate regression adjusted for age, previous other IHD (within 5 years prior admission), previous heart failure (within 5 years prior admission), previous CARP (during hospitalisation or within 28 days of discharge or within 5 years prior admission), previous BB dispensed (with 2 months prior admission), previous statins dispensed (with 2 months prior admission), previous ACEi/ARB dispensed (with 2 months prior admission), aspirin and/or clopidogrel dispensed within 28 days postdischarge, Charlson index.
†Also adjusted for gender.
ACEi/ARB, angiotensin-converting-enzyme inhibitor/angiotensin II receptor blockers; BB, β blockers; CARP, coronary artery revascularisation procedure; IHD, ischaemic heart disease; ST, statins.